Dr. Christian Meyer has served as uniQure's Chief Medical Officer since 2013. He is an experienced biopharma executive with more than 20 years of extensive Clinical Research, Regulatory Affairs, Medical Affairs and Pharmacovigilance background and with profound experience in all phases of pharmaceutical R&D of small molecules, biologics and gene therapy products. In addition, he has extensive R&D executive experience with an international track record of successfully building development units and secures value generation in the transition phase from R&D through Clinical Development and Commercialization. Dr. Meyer brings his experience from both biotechnology companies and large pharma’s in Scandinavia with particular expertise in the development of treatments for rare diseases.
Dr. Meyer joined uniQure from Cardoz AB where he spent three years as Chief Medical Officer. From 2006 to 2010, Dr. Meyer held leadership positions in Clinical Development at Symphogen A/S, where he was Senior Vice President for Medical Affairs and Vice President, Clinical Development. Prior to Symphogen, he played an important role in Clinical Development at Zymenex A/S and spent five years in Clinical Development at Novo Nordisk A/S. Dr. Meyer received both his M.D. and Ph.D. degrees from the University of Copenhagen, Denmark.